Table 1. Prevalence of PSA testing by covariates.
| N = 1,737 | Routine PSA test | |||
|---|---|---|---|---|
| Total | Yes | No | P value | |
| Patterns of Patient-Provider Discussions | <0.001 | |||
| No Discussion of Advantages or Disadvantages | 583 (29.6) | 87 (17.0) | 496 (83.0) | |
| Discussion of Disadvantages | 24 (1.5) | 13 (36.6) | 11 (63.4) | |
| Discussion of Advantages | 610 (34.9) | 522 (83.9) | 88 (16.1) | |
| Discussion of Advantages and Disadvantages | 520 (34.0) | 440 (88.2) | 80 (11.8) | |
| Provider ever recommended PSA test | <0.001 | |||
| No | 708 (37.4) | 119 (18.5) | 589 (81.5) | |
| Yes | 1,029 (62.6) | 943 (92.5) | 86 (7.5) | |
| Has a Personal Doctor | <0.001 | |||
| No | 159 (7.7) | 36 (18.9) | 123 (81.1) | |
| Yes (one or more than one) | 1,578 (92.3) | 1,026 (68.6) | 552 (31.4) | |
| Age, Median (IQR) | 60 (57–64) | 61 (58–65) | 58 (56–63) | <0.001 |
| Race/ethnicity | <0.001 | |||
| Black | 87 (5.7) | 45 (57.5) | 42 (42.5) | |
| Asian/Pacific Islander | 226 (10.9) | 98 (40.1) | 128 (59.9) | |
| Hispanic | 75 (3.7) | 38 (61.8) | 37 (38.2) | |
| White | 1,349 (79.7) | 881 (68.9) | 468 (31.1) | |
| Education | <0.001 | |||
| Less than High School | 68 (6.9) | 35 (58.2) | 33 (41.8) | |
| High School | 403 (27.9) | 199 (51.4) | 204 (48.6) | |
| Some College / Technical School | 414 (25.4) | 223 (62.5) | 191 (37.5) | |
| College / Technical School or more | 852 (39.8) | 605 (76.9) | 247 (23.1) | |
| Income | <0.001 | |||
| < $25,000 | 388 (15.8) | 159 (46.7) | 229 (53.3) | |
| $25,000 to < $50,000 | 373 (19.4) | 215 (59.1) | 158 (40.9) | |
| $50,000 to < $75,000 | 281 (19.0) | 188 (71.8) | 93 (28.3) | |
| ≥ $75,000 | 695 (45.8) | 500 (70.6) | 195 (29.4) | |
| Self-rated health | <0.05 | |||
| Fair or Poor | 312 (16.8) | 154 (53.8) | 158 (46.2) | |
| Good | 513 (30.2) | 296 (61.7) | 217 (38.4) | |
| Very Good | 581 (34.0) | 384 (71.1) | 197 (28.9) | |
| Excellent | 331 (19.0) | 228 (68.4) | 103 (31.6) | |
| Cancer Diagnosis | <0.001 | |||
| Yes | 298 (16.9) | 216 (78.7) | 82 (21.3) | |
| No | 1,439 (83.1) | 846 (62.0) | 593 (38.0) | |
| Diabetes | 0.54 | |||
| Yes | 275 (15.5) | 156 (62.1) | 119 (37.9) | |
| No | 1,462 (84.5) | 906 (65.3) | 556 (34.7) | |
| Asthmaa | 0.39 | |||
| Yes | 184 (11.4) | 124 (70.5) | 60 (29.5) | |
| No | 1,553 (88.6) | 938 (64.1) | 615 (35.9) | |
| Cerebrovascular Disease | 0.87 | |||
| Yes | 243 (13.0) | 141 (64.1) | 102 (35.9) | |
| No | 1494 (87.0) | 921 (64.9) | 573 (35.1) | |
| bInsurance Status | <0.001 | |||
| No | 90 (4.2) | 20 (16.0) | 70 (84.0) | |
| Yes | 1,647 (95.8) | 1,042 (67.0) | 605 (33.1) | |
| Delayed Care due to cost | <0.01 | |||
| Yes | 121 (6.4) | 49 (42.8) | 72 (57.3) | |
| No | 1,616 (93.7) | 1,013 (66.3) | 603 (33.7) | |
Source. Data from Centers for Disease Control and Prevention 2013 Behavioral Risk Factor Surveillance Survey. Analysis performed among the N = 1,737 participants with complete data on all covariates. Notes.
aYes, includes present or former asthma status.
bInsurance status is a point estimate and does not indicate whether the respondent was continually insured.